Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenlingcao Oral Liquid for Long COVID Associated Fatigue
NCT05684952Phase 2Unknown
- Sponsor
- Hong Kong Baptist University
- Start
- May 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of shenlingcao in post acute COVID-19 syndrome, sponsored by Hong Kong Baptist University. Status: unknown.
02
Drugs
shenlingcao
03
Conditions
post acute COVID-19 syndrome
Beyond the preview
Go deeper on NCT05684952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05684952.